Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
BSX CEO Buys 350K Shares
|
Rebecca Zacks |
10/10/08 |
|
|
|
What Does the Financial Crisis Mean for Innovation? Xconomists Weigh In
|
Robert Buderi |
09/30/08 |
|
|
|
Clinical Data Inks $25M Stock Deal
|
Rebecca Zacks |
09/29/08 |
|
|
|
Vertex Offering Up To $220M
|
Rebecca Zacks |
09/22/08 |
|
|
|
Cell Therapeutics Authorizes 1-for-10 Reverse Stock Split
|
Luke Timmerman |
08/25/08 |
|
|
|
GT Solar Pulls Off IPO, Esther Dyson and Tim O’Reilly Back Good Data, BioEnergy Bonds with OmniGene, & More Deals News
|
Rebecca Zacks |
07/28/08 |
|
|
|
GT Solar Set to Break IPO Drought
|
Wade Roush |
07/22/08 |
|
|
|
$37 Million for Nanotech Insulation, $25 Million for ImmunoGen, $325 Million for Evergreen Solar, & More Deals News
|
Rebecca Zacks |
06/30/08 |
|
|
|
Evergreen Solar Plans $300M Note Sale
|
Rebecca Zacks |
06/25/08 |
|
|
|
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News
|
Rebecca Zacks |
06/25/08 |
|
|
|
RXi Plans $8.7M Stock Sale
|
Rebecca Zacks |
06/24/08 |
|
|
|
Icahn Nominee Concedes Defeat at Biogen Idec Annual Meeting
|
Robert Buderi |
06/19/08 |
|
|
|
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process
|
Luke Timmerman |
06/05/08 |
|
|
|
Indevus Drug Delayed by FDA Safety Questions, Shares Plummet
|
Luke Timmerman |
06/04/08 |
|
|
|
Evergreen Rakes in the Green, NxStage Plans Two-Stage Deal, Atlas Places Big Bet on MicroRNA, & More Deals News
|
Rebecca Zacks |
05/27/08 |
|
|
|
Shares of Evergreen Solar Shine After $1 Billion Contract News
|
Rebecca Zacks |
05/22/08 |
|
|
|
Geezeo Takes a Walk on The Sunny Side of TheStreet.com
|
Wade Roush |
04/24/08 |
|
|
|
Dynogen, Apex Call Off Reverse Merger
|
Rebecca Zacks |
04/17/08 |
|
|
|
Monotype Files for SPO
|
Rebecca Zacks |
04/02/08 |
|
|
|
RXi’s Debut, Sirtris’ Surprising Deal, Hydra’s Big Financing Round, & More of the Last Week in Life Sciences
|
Rebecca Zacks |
03/19/08 |
|
|
|
Diomed Files for Bankruptcy, Plans Sale
|
Rebecca Zacks |
03/14/08 |
|
|
|
Mello RNAi Firm RXi Pharmaceuticals Has Wild Ride on First Day of Trading
|
Rebecca Zacks |
03/12/08 |
|
|
|
Curis, Alkermes Down on News of Failed Pharma Partnerships
|
Rebecca Zacks |
03/10/08 |
|
|
|
AspenTech Delisted from NASDAQ
|
Rebecca Zacks |
02/15/08 |
|
|
|
With a Whole Lot of Spending to Do, Vertex Seeks Some $400 Million in Stock and Note Offerings
|
Rebecca Zacks |
02/13/08 |
|
|
|
Evergreen Solar Plans Offering, ThingMagic Teams With Ford, Dynogen Reverse-Merges Onto the Market, & More
|
Rebecca Zacks |
02/12/08 |
|
|
|
Targanta Files for FDA Approval of Anti-MRSA Drug
|
Rebecca Zacks |
02/11/08 |
|
|
|
Dynogen Goes Public Via Reverse Merger
|
Rebecca Zacks |
02/06/08 |
|
|
|
Evergreen Solar Plans $230M Secondary Offering
|
Rebecca Zacks |
02/04/08 |
|
|
|
Elixir Postpones IPO
|
Rebecca Zacks |
01/17/08 |
|
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
